Children with neuroblastomas may benefit from new drug cocktail

Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumor drugs as well as chemotherapy, a new trial has found.

Related Keywords

Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,United Kingdom ,Gail Jackson ,Lucas Moreno ,Patricia Blanc ,Laura Danielson ,Cancer Research United Kingdom Clinical Trials Unit ,Hebron University Hospital ,International Society Of Paediatric Oncology European Neuroblastoma ,University Of Birmingham ,Clinical Oncology ,International Society ,Paediatric Oncology European Neuroblastoma ,Pediatric Hematology ,Chief Investigator ,United Kingdom Clinical Practice Guidelines ,Young People ,Research Lead ,Cancer Research United Kingdom ,Solving Kid Cancer United Kingdom ,Cancer ,Children ,Drugs ,Evacizumab ,Flood ,Blood Vessels ,Chemotherapy ,Nerve ,Neuroblastoma ,Ncology ,Research ,